RALYL and hepatocellular carcinoma: Among these, PITX2 and RALYL have been demonstrated to enhance cell stemness and metastatic abilities in hepatocellular carcinoma,28,29 but the expression levels of PITX2 and RALYL were not associated with liver metastasis in PDAC (data not shown).